Recruiting NA Breast Cancer Female

Tests treatment safety and results for Breast Cancer Female

Official title Assessment of Oncological Safety, Quality of Life, and Environmental Impact of the Green Breast Surgery Protocol

ClinicalTrials.gov ID: NCT06624917

What this study is testing

What it's testing
Breast Cancer (BC) is the primary oncological diagnosis in women, with the annual incidence expected to exceed 3 million new cases by 2040 due to population growth and aging. During the COVID-19 pandemic, novel methods were adopted worldwide to provide continuous patient care, including telehealth, fast-track protocols such as awake surgery in breast cancer.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 to 75, women only

You may be able to join if

  • Patients candidates for Breast Conserving Treatment
  • ASA score I-II
  • Availability to Telehealth assessment in the postoperative period

You likely can't join if

  • Drug addiction
  • contraindication for locoregional ultrasound-guided procedure (e.g., local infection, allergy to LA)
  • chronic pain under treatment
  • pregnancy
  • No follow-up planned in our facility

The study team makes the final eligibility decision.

Where it's taking place

  • Roma, Italy

Compensation & support

Compensation mentioned.

ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.

Questions & answers

Do participants get paid in this trial?

This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling female, 18 years to 75 years. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Roma, Italy. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.